SCHEMBL29469640

SCHEMBL29469640

CC(C)c1ccc(OCC2CC2)c(S(=O)(=O)NC(=O)c2cc3c(F)cc(N4CCC4)cc3o2)c1

nearest known ligand 0.39

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
ACACB O00763 5/20 0.39
SCN9A Q15858 9/20 0.36
SLC6A9 P48067 1/20 0.35
ALDH1A1 P00352 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
PDE4A P27815 1/20 0.35
PDE4B Q07343 1/20 0.35
PDE4C Q08493 1/20 0.35
PDE4D Q08499 1/20 0.35
SCN5A Q14524 2/20 0.34
SCN7A Q01118 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24333992 1.00 ACACB (0.39) ACACBSCN9ASLC6A9ALDH1A1SMN1; SMN2
SCHEMBL29469664 0.91 ALDH1A1 (0.44) ACACBALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL29469631 0.91 ACACB (0.40) ACACBALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL24333455 0.91 ACACB (0.40) ACACBALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL24334019 0.89 KCNH2 (0.39) SCN9ASLC6A9ALDH1A1SMN1; SMN2MEN1
SCHEMBL24333736 0.89 SCN9A (0.38) SCN9ASLC6A9ALDH1A1SCN5ASCN7A
SCHEMBL29469627 0.89 KCNH2 (0.39) SCN9ASLC6A9ALDH1A1SMN1; SMN2MEN1
SCHEMBL29469681 0.89 SCN9A (0.38) SCN9ASLC6A9ALDH1A1SCN5ASCN7A
SCHEMBL24333447 0.88 ALDH1A1 (0.38) SLC6A9ALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL29469624 0.88 ALDH1A1 (0.38) SLC6A9ALDH1A1SMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4229048-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER The Broad Institute, Inc. (US) 2023-08-23 EP claimed
WO-2022081807-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. (US) 2022-04-21 WO claimed
EP-4229048-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER The Broad Institute, Inc. (US) 2023-08-23 EP disclosed
WO-2022081807-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. (US) 2022-04-21 WO disclosed